Martin Auster joins Ascendis Pharma as Chief Business Officer Martin Auster joins Ascendis Pharma as Chief Business Officer The company uses its TransCon technology to create drugs that address unmet medical needs Seres Health appoints new President and CEO Seres Health appoints new President and CEO Roger Pomerantz was previously Head of Licensing & Acquisitions at Merck & Co Celerion establishes an operation in Singapore Celerion establishes an operation in Singapore To be headed by Chew Lan Chong as Executive Director, Medical Research Kymab makes two management appointments Kymab makes two management appointments Steve Arkinstall joins the company as Chief Scientific Officer and Nigel Clark as Head of Business Development Dieter Weinand to become President of Bayer HealthCare Pharmaceuticals Dieter Weinand to become President of Bayer HealthCare Pharmaceuticals Will take up the role from 1 August Bayer CEO Marijn Dekkers extends contract to the end of 2016 Bayer CEO Marijn Dekkers extends contract to the end of 2016 Werner Baumann appointed as Chief Strategy and Portfolio Officer and Johannes Dietsch to become Chief Financial Officer Gensignia appoints CEO at US subsidiary Gensignia appoints CEO at US subsidiary Lee McCracken joins the company from Pathwork Diagnostics New Sector Director role boosts offering to life sciences and manufacturing New Sector Director role boosts offering to life sciences and manufacturing Brendan Duigenan takes up a new role at Morgan Sindall Professional Services Ivan Gergel becomes SVP, Drug Development & Chief Medical Officer at Nektar Therapeutics Ivan Gergel becomes SVP, Drug Development & Chief Medical Officer at Nektar Therapeutics Joins the company from Endo Pharmaceuticals Gast Group appoints new President Gast Group appoints new President Kim Fields takes responsibility for Gast and Jun-Air brands Andreas Fibig to leave Bayer HealthCare Pharmaceuticals Andreas Fibig to leave Bayer HealthCare Pharmaceuticals Will join International Flavors & Fragrances in New York on 1 September Dr Sy Pretorius gains a promotion at Parexel Dr Sy Pretorius gains a promotion at Parexel Becomes Chief Scientific Officer and will continue to lead global Phase I and IIa services Peter George joins Board of Ergomed as Non-Executive Director Peter George joins Board of Ergomed as Non-Executive Director He is currently Chief Executive of Clinigen SGS makes key appointments at new California facility SGS makes key appointments at new California facility Carson, California plant is due to open in the third quarter 2014 Jazz Pharmaceuticals names Russell Cox as Chief Operating Officer Jazz Pharmaceuticals names Russell Cox as Chief Operating Officer Cox was formerly EVP and Chief Commercial Officer at the biopharmaceuticals company Brookfield names Gerhard Baumann as Managing Director for Brookfield Germany Brookfield names Gerhard Baumann as Managing Director for Brookfield Germany Takes responsibility for the full line of Brookfield laboratory instruments Pharmagen recruits Frederick Mundt as Senior Vice President of Sales Pharmagen recruits Frederick Mundt as Senior Vice President of Sales Has been in the industry for more than 20 years Amgen appoints regulatory affairs and safety specialist Amgen appoints regulatory affairs and safety specialist Steven Galson gains a promotion GenSight Biologics appoints Jean-Philippe Combal as Chief Operating Officer GenSight Biologics appoints Jean-Philippe Combal as Chief Operating Officer He brings extensive experience in ophthalmologic diseases to the French company Sven Andreasson joins Novavax as SVP of Corporate Development Sven Andreasson joins Novavax as SVP of Corporate Development Formerly CEO of Isconova, which was acquired by Novavax last year Midatech makes two appointments Midatech makes two appointments Strengthening the Board and senior management team Astellas makes a promotion and a new appointment Astellas makes a promotion and a new appointment In Global Development and Global Medical Affairs Kenneth Sommerville joins GW Pharmaceuticals as VP of Clinical Science Kenneth Sommerville joins GW Pharmaceuticals as VP of Clinical Science To support US medical affairs and regulatory activities related to epilepsy programmes Sygnature Discovery hires Director of Business Development Sygnature Discovery hires Director of Business Development Dr Gerry Thomas joins the company